249420 — Il Dong Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Market Cap
KR₩331bn
Enterprise Value
KR₩471bn
Revenue
KR₩615bn

Annual balance sheet for Il Dong Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	86,164	154,681	78,746	62,758	72,267
Net Total Accounts Receivable
Net Total Receivables	51,588	55,145	58,326	62,975	66,977
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	233,243	301,550	282,035	235,681	246,991
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	256,419	247,790	255,317	256,380	221,443
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	605,277	708,970	655,810	611,261	589,043
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	185,010	364,141	316,290	314,230	243,653
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	350,730	556,062	464,567	441,718	428,285
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	254,547	152,909	191,244	169,543	160,758
Total Liabilities & Shareholders' Equity	605,277	708,970	655,810	611,261	589,043
Total Common Shares Outstanding